
VisCardia Honored with Prestigious Innovation Award at EuroPCR 2025 for Groundbreaking Heart Failure Therapy
PARIS, FRANCE, May 21, 2025 /EINPresswire.com/ -- VisCardia, Inc., the developer of a disruptive therapy for heart failure, proudly announced today that it has received the prestigious Jon DeHaan Foundation Award for Innovation in Cardiology at …